Acquisition
Zenex buys majority stake in VievePharm
By Startup Enthusiast ·
- Date
- Company
- Zenex Animal Health
- What it does
- Zenex Animal Health
- Kind
- Acquisition
- Based in
- Ahmedabad
What they do
Zenex took a controlling share in VievePharm, a Dutch maker of natural animal nutrition products, for an undisclosed price
What happened
The deal gives the Indian firm a factory and sales base in Western Europe, where rules on antibiotics are tightening
Why it matters
VievePharm's bolus (large slow-release tablet) know-how for minerals, vitamins and udder health will join Zenex's global range
The details
- Zenex Animal Health India bought a majority stake in VievePharm of the Netherlands.
- VievePharm makes plant-based feed formulations for livestock, horses and pets.
- It is based in Enter, in the Netherlands.
- The EU wants veterinary antibiotic sales cut by 50% by 2030 from 2018 levels.
The deal
- Type
- Majority stake
More on Zenex Animal Health
- Zenex buys SAVAVET pet care business30 September 2026 · Acquisition
- Aniruddha Rajurkar named Zenex chief executive10 April 2026 · People
- Nitendra Patel joins Zenex as HR chief15 December 2025 · People
- Zenex acquires herbal animal care firm Ayurvet14 December 2023 · Acquisition
- IFC and EAF to buy $52.5M Zenex stake6 December 2021 · Funding · $52.5 million
Same day
- DailyObjects crosses ₹320 crore annual run rate27 February 2026 · Results
- Ferns N Petals revenue rises 22% in FY2527 February 2026 · Results
- Glovatrix builds sign language translation device27 February 2026 · Milestone · ₹1.7 crore
- Mygate narrows loss, achieves EBITDA breakeven in FY2527 February 2026 · Results
- Lenskart stock hits new high following robust quarterly results27 February 2026 · Results
- Milky Mist plans ₹2,035 crore IPO in 202627 February 2026 · IPO · ₹2,035 crore